John Tsai, Head of Global Drug Development and Chief Medical Officer, describes how he balances innovation and patient needs.

Inside the hunt for new antivirals to combat the current pandemic and to prepare for future ones.

Combinations of drugs could hold the key to overcoming some of the biggest challenges in lung and other cancers.

Inspired by Emily Whitehead, along with other early patients treated with CAR-T cell therapy, Novartis embarked on a pioneering journey to reimagine cancer treatment. After 10 years, we continue to relentlessly pursue new science around cell and gene therapies to transform the lives of patients today and in the future.